These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 22489357)
1. Splenic lymphomas: is there still a role for splenectomy? Martin P; Rutherford S; Leonard JP Oncology (Williston Park); 2012 Feb; 26(2):204, 206. PubMed ID: 22489357 [No Abstract] [Full Text] [Related]
2. Marginal zone lymphomas: management of nodal, splenic, and MALT NHL. Kahl B; Yang D Hematology Am Soc Hematol Educ Program; 2008; ():359-64. PubMed ID: 19074110 [TBL] [Abstract][Full Text] [Related]
3. Clinical and biological diversity of splenic marginal zone lymphoma. Matutes E Expert Rev Anticancer Ther; 2009 Sep; 9(9):1185-9. PubMed ID: 19761421 [No Abstract] [Full Text] [Related]
4. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation. Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947 [TBL] [Abstract][Full Text] [Related]
5. Splenic marginal zone lymphoma associated with hepatitis B virus infection, remission after viral treatment, and splenectomy: A case report and review of the literature. Ababou M; Mahtat EM; Jennane S; Elmaaroufi H; Mikdame M; Doghmi K Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):153-155. PubMed ID: 31306619 [TBL] [Abstract][Full Text] [Related]
9. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era. Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961 [TBL] [Abstract][Full Text] [Related]
10. Splenic marginal zone lymphoma in a patient with chronic hepatitis B. Christou L; Kalambokis G; Bai M; Kamina S; Tsianos EV J Gastrointestin Liver Dis; 2009 Dec; 18(4):511-2. PubMed ID: 20076834 [No Abstract] [Full Text] [Related]
16. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification. Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505 [TBL] [Abstract][Full Text] [Related]
17. Splenic marginal zone lymphoma leads to sinistral portal hypertension. Lv XH; Ma LL; Fu WY; Xie Y J Dig Dis; 2019 Jan; 20(1):45-48. PubMed ID: 30549195 [No Abstract] [Full Text] [Related]
18. Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab. Bennett M; Schechter GP Semin Hematol; 2010 Apr; 47(2):143-7. PubMed ID: 20350661 [TBL] [Abstract][Full Text] [Related]
19. Survival outcomes with and without splenectomy in splenic marginal zone lymphoma. Olszewski AJ Am J Hematol; 2012 Nov; 87(11):E119-22. PubMed ID: 22887176 [TBL] [Abstract][Full Text] [Related]
20. Pseudo-faggot cells in splenic marginal zone lymphoma. Wilson J Br J Haematol; 2023 Apr; 201(1):7. PubMed ID: 36606572 [No Abstract] [Full Text] [Related] [Next] [New Search]